Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer
Sign Up to like & getrecommendations! Published in 2021 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2020.7932
Abstract: This phase 3 randomized clinical trial compares the clinical efficacy of margetuximab vs trastuzumab, each with chemotherapy, in patients with pretreated ERBB2-positive advanced breast cancer. read more here.
Keywords: pretreated erbb2; erbb2 positive; efficacy margetuximab; margetuximab trastuzumab ... See more keywords